Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000945234-03-000152
Filing Date
2003-03-28
Accepted
2003-03-28 14:34:51
Documents
10
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT YEAR ENDED DECEMBER 31, 2002 o09305e10vk.txt 10-K 363305
3 DEFINITIVE DEVELOPMENT & COMMERCIALIZATION AGMNT o09305exv10w76.txt EX-10.76 249619
4 EMPLOYMENT AGREEMENT PAUL J. HASTINGS o09305exv10w77.txt EX-10.77 56337
5 EMPLOYMENT AGREEMENT MICHAEL J. DOTY o09305exv10w78.txt EX-10.78 53120
6 EMPLOYMENT AGREEMENT WILLIAM J. NEWELL o09305exv10w79.txt EX-10.79 46171
7 EMPLOYMENT AGREEMENT ALAIN CURAUDEAU o09305exv10w80.txt EX-10.80 44171
8 COMPUTATION OF PER SHARE EARNINGS o09305exv11.txt EX-11 1784
9 CONSENT OF DELOITTE & TOUCHE LLP o09305exv23.txt EX-23 523
10 SECTION 906 CERTIFICATION CEO o09305exv99w1.txt EX-99.1 1617
11 SECTION 906 CERTIFICATION CFO o09305exv99w2.txt EX-99.2 1717
  Complete submission text file 0000945234-03-000152.txt   821339
Mailing Address 123 TESTING ST. CHICAGO IL 11111
Business Address 520 W 6TH AVE STE 200 VANCOUVER BC CANADA A1 6048727881
QLT INC/BC (Filer) CIK: 0000827809 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-17082 | Film No.: 03624491
SIC: 2834 Pharmaceutical Preparations